文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

澳大利亚GBQ+人群淋病疫苗接受意愿高

High willingness to receive a vaccine for gonorrhoea prevention among gay, bisexual, queer, and other sexuality diverse men, and non-binary people in Australia.
PubMed 文献 · Vaccine · 2026-10-13

研究基于2025年澳大利亚≥16岁GBQ+人群横断面调查(n=2138),分析接种4CMenB疫苗预防淋病的意愿。89.2%表示愿意接种;≥30岁和境外出生者意愿较低,近期使用HIV PrEP、熟悉抗菌素耐药及愿意性行为后服用抗生素预防STI者意愿较高。意愿与预防参与和生物医学预防态度更相关,而非性风险行为。

要点

  • GBQ+人群对淋病疫苗接受意愿高(89.2%)。
  • ≥30岁及境外出生者接种意愿较低。
  • 熟悉抗菌素耐药及使用HIV PrEP者意愿更高。

核心结论

  • GBQ+人群对4CMenB疫苗预防淋病的接受意愿高,且与预防参与和生物医学预防态度相关。

研究设计与样本

  • 2025年澳大利亚≥16岁GBQ+人群横断面调查,共2138名参与者(中位年龄39岁),采用多变量logistic回归分析相关因素。

主要发现

  • 89.2%的参与者愿意接种4CMenB疫苗预防淋病。
  • ≥30岁者意愿较低(aOR=0.46;95%CI=0.29-0.74),境外出生者意愿较低(aOR=0.71;95%CI=0.51-0.99)。
  • 近期使用HIV PrEP者意愿较高(aOR=2.80;95%CI=1.30-5.99)。
  • 熟悉抗菌素耐药者意愿较高(aOR=2.26;95%CI=1.61-3.18)。
  • 愿意性行为后服用抗生素预防STI者意愿较高(aOR=5.42;95%CI=3.85-7.61)。

临床怎么用

  • 未来淋病疫苗在该人群中可能具有较高接受度,可结合预防参与和生物医学预防态度进行推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gonorrhoea incidence and antimicrobial resistance are increasing among gay, bisexual, queer, and other sexuality diverse men, and non-binary (GBQ+) people. Observational studies suggested that 4CMenB vaccine (Bexsero®) may provide partial protection against gonorrhoea, but recent randomised trials found no clear evidence of protection. We analysed willingness to receive 4CMenB for gonorrhoea prevention in a 2025 Australian cross-sectional survey of GBQ+ individuals aged ≥16 years. Multivariable logistic regression examined associated factors. Among 2138 participants (median age 39 years), 89.2% were willing to be vaccinated. Willingness was lower among participants aged ≥30 (aOR = 0.46;95%CI = 0.29-0.74), born outside Australia (aOR = 0.71;95%CI = 0.51-0.99), higher among those reporting recent HIV PrEP use (aOR = 2.80;95%CI = 1.30-5.99), familiarity with antimicrobial resistance (aOR = 2.26;95%CI = 1.61-3.18), and willingness to take an antibiotic pill after sex to prevent STIs (aOR = 5.42;95%CI = 3.85-7.61). Willingness was high and aligned more with prevention engagement and biomedical prevention attitudes than with sexual risk behaviours, suggesting future gonorrhoea vaccines may be acceptable in this population.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hammoud M, Holt M, Broady TR, et al. High willingness to receive a vaccine for gonorrhoea prevention among gay, bisexual, queer, and other sexuality diverse men, and non-binary people in Australia. Vaccine. 2026. PMID: 42869876. doi:10.1016/j.vaccine.2026.129233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。